A new weapon against C. diff bacteria
01 February, 2024In a phase-one human clinical trial, a US pharmacist researcher has shown that a newer generation tetracycline antibiotic could help combat Clostridioides difficile (C. diff) bacteria.
80-year Buruli ulcer mystery solved
25 January, 2024A recent alarming surge in cases caused this tropical skin disease to become an important public health issue in Victoria.
Managing the "opportunistic invasive" fungal pathogens
24 January, 2024Invasive fungal infections are a growing risk to human health worldwide, with the World Health Organization releasing its first-ever watchlist of fungal priority pathogens — species of highest concern that require serious attention.
Project to eliminate parasitic disease in remote communities
16 January, 2024A QIMR Berghofer-led project aims to eliminate strongyloidiasis, a little-known and potentially fatal infection that thrives in communities with poor sanitation.
Do hospital coffee machines transmit infections?
19 December, 2023Microbial growth was detected on every coffee machine and hospital machines were found to be about three times as heavily colonised as home machines.
TGA advises of possible saline contamination
04 December, 2023A recent outbreak of Ralstonia pickettii in Australian hospital patients has been linked to contaminated saline.
Charm novaLUM II-X system
28 November, 2023The novaLUM II-X system brings together Charm’s ATP (adenosine triphosphate) detection technology and new novaLINK 5 software for a system designed to make sanitation verification, corrective action and documentation easier.
WHO responds to upsurge of respiratory illness in China
24 November, 2023The World Health Organization has shared an update on the increase in respiratory illnesses among children in northern China.
The hard facts about Australia's antimicrobial use
17 November, 2023The Australian Commission on Safety and Quality in Health Care has released its most recent report into the nation's antibiotic use and resistance.
New mRNA network to accelerate clinical translation
06 November, 2023The network aims to advance mRNA medicine, foster scientific excellence in clinical translation and further the therapeutic potential of the mRNA platform.
Alarming resistance rates prompt calls for updated antibiotic guidelines
01 November, 2023Antibiotics to treat common infections in children and babies are no longer effective, due to high rates of resistance, reveals new research.
Infectious diseases researcher recognised
30 October, 2023UNSW infectious diseases researcher Dr Lise Lafferty has been recognised with the Paul Bourke Award for her approach to managing hepatitis C in prisons.
trophon2®: confidence without compromise
23 October, 2023The trophon2 device is the latest addition to the trophon family. It has an enhanced user experience and offers health professionals the confidence of the broadest microbial efficacy, plus digital traceability and consistent protection for every patient, every time.
Extra antibiotics to prevent joint replacement infections don't help: trial
23 October, 2023A clinical trial has found that in joint replacement infection, the addition of vancomycin may lead to more infections and more adverse reactions for the patients.
Guillain-Barré syndrome risk six times higher after COVID-19: study
20 October, 2023Having a COVID-19 infection is associated with an increased risk of developing Guillain-Barré syndrome within the next six weeks, according to a new study.
